Sent September 11, 2022 12:30 PMUp to date September 11, 2022 at 12:34 pm
Franco-Swiss biotechnology team designed in 2018 and specializing in cell therapies, MedXCell intends to create a “start-up studio” model in Montpellier in the cell treatment sector. On the identical system will sign up for PhD learners from the pharmaceutical sector, information experts, engineers, laboratory experts, scientists from the community sector … This biotechnology accelerator aims to identify substantial-level jobs with tutorial partners, validate their financial likely, to construction the enhancement, then to build independent biotherapy firms.
MedXCell has partnered with CHU, College of Montpellier, SATT AxLR, CNRS, Inserm and the Federal Polytechnic Faculty of Lausanne. “The target is to reproduce products in Montpellier that are Elevate Bio in Boston, CCRM in Toronto or Catapult in the Uk,” clarifies Laurent Zbinden, executive director of MedXCell. “We fund research teams to aid modern tasks,” sums up Laurent Zbinden. he does it
–
